403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Spectral Medical Inc.
(MENAFN- Baystreet) 10:11 AM EST - Spectral Medical Inc.: Provided an update following its in-person 100-Day Meeting with the U.S. Food and Drug Administration regarding the Company's Premarket Approval application for Toraymyxin. Spectral Medical Inc.
shares T are trading down $0.01 at $1.25.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment